DK2451814T3 - Kondenserede imidazoler og sammensætninger indeholdende disse til behandling af parasitiske sygdomme, såsom fx malaria - Google Patents
Kondenserede imidazoler og sammensætninger indeholdende disse til behandling af parasitiske sygdomme, såsom fx malariaInfo
- Publication number
- DK2451814T3 DK2451814T3 DK10733107.6T DK10733107T DK2451814T3 DK 2451814 T3 DK2451814 T3 DK 2451814T3 DK 10733107 T DK10733107 T DK 10733107T DK 2451814 T3 DK2451814 T3 DK 2451814T3
- Authority
- DK
- Denmark
- Prior art keywords
- imidazols
- malaria
- condensed
- treatment
- compositions containing
- Prior art date
Links
- 208000030852 Parasitic disease Diseases 0.000 title 1
- 201000004792 malaria Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/022—Boron compounds without C-boron linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22443309P | 2009-07-09 | 2009-07-09 | |
| PCT/US2010/041626 WO2011006143A2 (en) | 2009-07-09 | 2010-07-09 | Compounds and compositions for the treatment of parasitic diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2451814T3 true DK2451814T3 (da) | 2014-07-14 |
Family
ID=42727573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10733107.6T DK2451814T3 (da) | 2009-07-09 | 2010-07-09 | Kondenserede imidazoler og sammensætninger indeholdende disse til behandling af parasitiske sygdomme, såsom fx malaria |
Country Status (38)
| Country | Link |
|---|---|
| US (3) | US8557801B2 (da) |
| EP (2) | EP2737927B1 (da) |
| JP (1) | JP5432376B2 (da) |
| KR (1) | KR101378666B1 (da) |
| CN (1) | CN102471341B (da) |
| AR (1) | AR077463A1 (da) |
| AU (1) | AU2010271247B2 (da) |
| BR (1) | BR112012000413B1 (da) |
| CA (1) | CA2767664C (da) |
| CL (1) | CL2012000042A1 (da) |
| CO (1) | CO6491060A2 (da) |
| CR (1) | CR20120008A (da) |
| CU (1) | CU24155B1 (da) |
| DK (1) | DK2451814T3 (da) |
| EA (1) | EA019655B1 (da) |
| EC (1) | ECSP12011585A (da) |
| ES (2) | ES2477940T3 (da) |
| GT (1) | GT201200004A (da) |
| HK (1) | HK1164304A1 (da) |
| HN (1) | HN2012000023A (da) |
| HR (1) | HRP20140641T1 (da) |
| IL (1) | IL217384A (da) |
| JO (1) | JO3156B1 (da) |
| MA (1) | MA33419B1 (da) |
| MX (1) | MX2012000389A (da) |
| MY (1) | MY157238A (da) |
| NZ (1) | NZ597275A (da) |
| PE (1) | PE20130399A1 (da) |
| PL (1) | PL2451814T3 (da) |
| PT (1) | PT2451814E (da) |
| SG (1) | SG176938A1 (da) |
| SI (1) | SI2451814T1 (da) |
| SM (1) | SMT201400096B (da) |
| TN (1) | TN2011000647A1 (da) |
| TW (1) | TWI421252B (da) |
| UA (1) | UA103930C2 (da) |
| UY (1) | UY32776A (da) |
| WO (1) | WO2011006143A2 (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2920169A1 (en) | 2012-11-14 | 2015-09-23 | F. Hoffmann-La Roche AG | Imidazopyridine derivatives |
| PT2925757T (pt) * | 2012-11-19 | 2018-01-09 | Novartis Ag | Compostos e composições para o tratamento de doenças parasitárias |
| US8871754B2 (en) | 2012-11-19 | 2014-10-28 | Irm Llc | Compounds and compositions for the treatment of parasitic diseases |
| US20150291598A1 (en) * | 2012-11-19 | 2015-10-15 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| CN103126782B (zh) * | 2013-02-26 | 2016-06-29 | 内蒙古农牧业科学院 | 一种寄生病的治疗方法 |
| HUE040254T2 (hu) * | 2013-12-19 | 2019-02-28 | Novartis Ag | Protozoa proteaszóma inhibitor [1,2,4]triazolo[1,5-a]pirimidinszármazékok paraziták által okozott betegségek, például leishmaniasis kezelésére |
| ES2757052T3 (es) | 2015-07-31 | 2020-04-28 | Merck Patent Gmbh | Derivados heterocíclicos bicíclicos |
| PE20190800A1 (es) | 2016-08-15 | 2019-06-10 | Bayer Cropscience Ag | Derivados del heterociclo biciclico condensado como agentes de control de plagas |
| TWI791515B (zh) * | 2017-04-24 | 2023-02-11 | 瑞士商諾華公司 | 治療療法 |
| FI3652178T3 (fi) | 2017-07-14 | 2024-03-19 | Hoffmann La Roche | Bisyklisiä ketoniyhdisteitä ja niiden käyttömenetelmiä |
| EP3692052A4 (en) * | 2017-10-04 | 2021-03-17 | Dana Farber Cancer Institute, Inc. | INHIBITION BY SMALL MOLECULES OF THE TRANSCRIPTION FACTOR SALL4 AND ITS USES |
| WO2022049548A1 (en) | 2020-09-04 | 2022-03-10 | Novartis Ag | Kaf156 combinations and methods for the treatment of malaria |
| WO2023168107A2 (en) * | 2022-03-04 | 2023-09-07 | University Of Central Florida Research Foundation, Inc. | Compounds and compositions for anitmalarial therapeutic and prophylactic use |
| CN114569711B (zh) * | 2022-03-24 | 2024-04-19 | 安徽医科大学 | 一种预防弓形虫病的ME49Δcdpk3减毒活疫苗及其制备方法和应用 |
| WO2024006971A2 (en) * | 2022-07-01 | 2024-01-04 | The Scripps Research Institute | Antimalarial compounds |
| WO2024006970A2 (en) * | 2022-07-01 | 2024-01-04 | The Scripps Research Institute | Antimalarial compounds |
| WO2024006974A2 (en) * | 2022-07-01 | 2024-01-04 | The Scripps Research Institute | Antimalarial compounds |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK476885D0 (da) | 1985-10-17 | 1985-10-17 | Ferrosan As | Heterocycliske forbindelser og fremgangsmaader til fremstilling heraf |
| US6673927B2 (en) | 1996-02-16 | 2004-01-06 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Farnesyl transferase inhibitors |
| CZ20004568A3 (cs) | 1998-06-12 | 2001-11-14 | Societe De Conseils De Recherches Et D'application | Sloučenina imidazolylu, farmaceutický prostředek a způsob výroby |
| FR2780974B1 (fr) | 1998-07-08 | 2001-09-28 | Sod Conseils Rech Applic | Utilisation de derives d'imidazopyrazines pour preparer un medicament destine a traiter les pathologies qui resultent de la formation de la proteine g heterotrimetrique |
| DE69915514T2 (de) * | 1998-12-31 | 2005-01-05 | Société de Conseils de Recherches et d'Applications Scientifiques S.A.S. | Prenyltransferase-inhibitoren |
| RU2298417C2 (ru) | 1999-11-09 | 2007-05-10 | Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик (С.К.Р.А.С.) | Продукт, включающий ингибитор трансдукции сигналов гетеротримерных протеинов g в комбинации с другим цитостатическим средством, для терапевтического применения при лечении рака |
| FR2803525B1 (fr) | 2000-01-06 | 2002-05-03 | Sod Conseils Rech Applic | Inhibiteur de la transduction des signaux des proteines g heterotrimeriques associe a un agent anti-hypertenseur dans le traitement de l'hypertension arterielle |
| WO2002010140A2 (en) | 2000-08-01 | 2002-02-07 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Imidazolyl derivatives |
| CN1237060C (zh) * | 2001-01-02 | 2006-01-18 | 弗·哈夫曼-拉罗切有限公司 | 用作α1A/B肾上腺素能受体拮抗剂的喹唑酮衍生物 |
| FR2825278A1 (fr) | 2001-05-30 | 2002-12-06 | Sod Conseils Rech Applic | Produit comprenant du mikanolide, du dihydromikanolide ou un analogue de ceux-ci en association avec un autre agent anti-cancereux pour une utilisation therapeutique dans le traitement du cancer |
| UA74912C2 (en) * | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| DE60316416T2 (de) | 2002-03-25 | 2008-06-26 | Merck & Co., Inc. | Heterocyclische beta-aminoverbindungen als inhibitoren der dipeptidylpeptidase zur behandlung bzw. prävention von diabetes |
| AU2003274565A1 (en) | 2002-09-27 | 2004-04-19 | Centre National De Recherche Scientifique | Composition for the treatment of nasopharyngeal carcinoma and use thereof |
| WO2004058266A1 (en) * | 2002-12-20 | 2004-07-15 | Merck & Co., Inc. | 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| EP1572682A4 (en) | 2002-12-20 | 2008-01-23 | Pharmacia Corp | ACYCLIC PYRAZOLE COMPOUNDS |
| US7504501B2 (en) * | 2003-03-06 | 2009-03-17 | Merial Limited | Antiprotozoal imidazopyridine compounds |
| TW200505902A (en) * | 2003-03-20 | 2005-02-16 | Schering Corp | Cannabinoid receptor ligands |
| EP1624874B1 (en) | 2003-05-14 | 2009-11-04 | Merck & Co., Inc. | 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| FR2856688B1 (fr) | 2003-06-25 | 2008-05-30 | Sod Conseils Rech Applic | PRODUIT COMPRENANT AU MOINS UN INHIBITEUR DE PHOSPHATASE CDc25 EN ASSOCIATION AVEC AU MOINS UN AUTRE AGENT ANTI-CANCEREUX |
| FR2867778B1 (fr) * | 2004-03-16 | 2006-06-09 | Sanofi Synthelabo | Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme |
| CA2617715A1 (en) | 2005-08-11 | 2007-02-15 | F. Hoffmann-La Roche Ag | Pharmaceutical composition comprising a dpp-iv inhibitor |
| RU2318818C1 (ru) | 2006-04-12 | 2008-03-10 | Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" | Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция и способ получения (варианты) |
| EP2010180A4 (en) | 2006-04-21 | 2010-10-13 | Glaxosmithkline Llc | IL-8 RECEPTOR ANTAGONISTS |
| US20120142623A1 (en) | 2006-07-07 | 2012-06-07 | Michael Lagunoff | Compositions And Methods For Predicting Inhibitors Of Protein Targets |
| TW200808056A (en) * | 2006-07-26 | 2008-02-01 | Compal Communications Inc | Rear projection display system |
| CN101622001A (zh) | 2007-01-26 | 2010-01-06 | Irm责任有限公司 | 作为激酶抑制剂用于治疗疟原虫相关疾病的嘌呤化合物和组合物 |
| US20080242862A1 (en) * | 2007-03-27 | 2008-10-02 | Calderwood David J | Novel imidazo based heterocycles |
| WO2009005675A1 (en) | 2007-06-28 | 2009-01-08 | Abbott Laboratories | Novel triazolopyridazines |
| CN101357922B (zh) | 2007-08-02 | 2011-05-18 | 山东轩竹医药科技有限公司 | 新的dpp-iv抑制剂 |
| EP2085398A1 (en) | 2008-02-01 | 2009-08-05 | Merz Pharma GmbH & Co. KGaA | Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| EP2090576A1 (en) | 2008-02-01 | 2009-08-19 | Merz Pharma GmbH & Co.KGaA | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators |
| CN102131805A (zh) | 2008-06-20 | 2011-07-20 | 百时美施贵宝公司 | 用作激酶抑制剂的咪唑并吡啶和咪唑并吡嗪化合物 |
-
2010
- 2010-07-08 TW TW099122545A patent/TWI421252B/zh active
- 2010-07-08 JO JOP/2010/0245A patent/JO3156B1/ar active
- 2010-07-08 AR ARP100102479A patent/AR077463A1/es active IP Right Grant
- 2010-07-08 UY UY0001032776A patent/UY32776A/es active IP Right Grant
- 2010-07-09 AU AU2010271247A patent/AU2010271247B2/en active Active
- 2010-07-09 ES ES10733107.6T patent/ES2477940T3/es active Active
- 2010-07-09 DK DK10733107.6T patent/DK2451814T3/da active
- 2010-07-09 KR KR1020127003375A patent/KR101378666B1/ko active IP Right Grant
- 2010-07-09 MX MX2012000389A patent/MX2012000389A/es active IP Right Grant
- 2010-07-09 EA EA201200098A patent/EA019655B1/ru not_active IP Right Cessation
- 2010-07-09 ES ES14156496.3T patent/ES2574529T3/es active Active
- 2010-07-09 EP EP14156496.3A patent/EP2737927B1/en active Active
- 2010-07-09 NZ NZ597275A patent/NZ597275A/xx unknown
- 2010-07-09 EP EP10733107.6A patent/EP2451814B1/en active Active
- 2010-07-09 CN CN201080029052.1A patent/CN102471341B/zh active Active
- 2010-07-09 CU CU20120002A patent/CU24155B1/es active IP Right Grant
- 2010-07-09 PE PE2012000026A patent/PE20130399A1/es active IP Right Grant
- 2010-07-09 WO PCT/US2010/041626 patent/WO2011006143A2/en active Application Filing
- 2010-07-09 PT PT107331076T patent/PT2451814E/pt unknown
- 2010-07-09 UA UAA201200238A patent/UA103930C2/ru unknown
- 2010-07-09 PL PL10733107T patent/PL2451814T3/pl unknown
- 2010-07-09 MY MYPI2011006324A patent/MY157238A/en unknown
- 2010-07-09 SG SG2011094612A patent/SG176938A1/en unknown
- 2010-07-09 SI SI201030656T patent/SI2451814T1/sl unknown
- 2010-07-09 JP JP2012519791A patent/JP5432376B2/ja active Active
- 2010-07-09 MA MA34520A patent/MA33419B1/fr unknown
- 2010-07-09 BR BR112012000413-1A patent/BR112012000413B1/pt active IP Right Grant
- 2010-07-09 US US12/833,909 patent/US8557801B2/en active Active
- 2010-07-09 CA CA2767664A patent/CA2767664C/en active Active
-
2011
- 2011-12-16 TN TNP2011000647A patent/TN2011000647A1/en unknown
-
2012
- 2012-01-05 IL IL217384A patent/IL217384A/en active IP Right Grant
- 2012-01-05 HN HN2012000023A patent/HN2012000023A/es unknown
- 2012-01-06 CL CL2012000042A patent/CL2012000042A1/es unknown
- 2012-01-06 GT GT201200004A patent/GT201200004A/es unknown
- 2012-01-09 EC EC2012011585A patent/ECSP12011585A/es unknown
- 2012-01-09 CR CR20120008A patent/CR20120008A/es unknown
- 2012-01-19 CO CO12007883A patent/CO6491060A2/es active IP Right Grant
- 2012-05-17 HK HK12104874.9A patent/HK1164304A1/xx unknown
-
2013
- 2013-06-07 US US13/912,898 patent/US9469645B2/en active Active
-
2014
- 2014-07-07 HR HRP20140641AT patent/HRP20140641T1/hr unknown
- 2014-07-22 SM SM201400096T patent/SMT201400096B/xx unknown
-
2015
- 2015-12-22 US US14/978,059 patent/US9963454B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2451814T3 (da) | Kondenserede imidazoler og sammensætninger indeholdende disse til behandling af parasitiske sygdomme, såsom fx malaria | |
| DK2504005T3 (da) | Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme | |
| DK2240155T3 (da) | Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler | |
| DK2220116T3 (da) | Sammensætninger og fremgangsmåder til terapien og diagnosticeringen af influenza | |
| DK2137537T3 (da) | Sammensætninger og anvendelser til behandling af multipel sklerose | |
| DK2796469T3 (da) | Hidtil ukendte sammensætninger og fremgangsmåder til behandling af IgE-medierede forstyrrelser | |
| DK2114886T3 (da) | Fremgangsmåde til fremstilling af visse substituerede sulfiliminer | |
| DK2445912T3 (da) | Ny forbindelse anvendelig til behandlingen af degenerative og inflammatoriske sygdomme | |
| DK2086944T3 (da) | Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater | |
| DK2346321T4 (da) | Sammensætning til forbedring af effektiviteten af herbicider | |
| DK2632954T4 (da) | Midler og fremgangsmåder til behandling af dlbcl | |
| DK2474321T3 (da) | Sammensætninger til behandling af collagenmedierede sygdomme | |
| DK1893586T3 (da) | Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler | |
| DK2635282T3 (da) | Sammensætninger til behandling af myelofibrose | |
| DK2285808T3 (da) | Spiroindolderivater til behandling af parasitsygdomme | |
| DK2209900T3 (da) | Anvendelse af bakterier til fremstillingen af bioenergi | |
| DK3246042T3 (da) | Lægemiddelresistent immunterapi til behandling af cancer | |
| DK2598500T3 (da) | Sammensætninger og fremgangsmåder til hæmning af jak-reaktionsvejen | |
| DK2533761T3 (da) | Fremgangsmåder og sammensætninger til fremstilling af aerosoler | |
| DK3284820T3 (da) | Fremgangsmåde til behandling af pyropheophytin-holdige sammensætninger | |
| DK2467364T3 (da) | Nitrogen-holdige forbindelser og farmaceutiske sammensætninger for behandling af atrial flimren. | |
| DK2456544T3 (da) | Fremgangsmåde til fjernelse af gasformig væske og indretning dertil | |
| DK2146944T3 (da) | Fremgangsmåde til fremstillingen af 18f-mærkede folater | |
| DK2117565T3 (da) | Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme | |
| CL2014002318A1 (es) | Procedimiento para la separación de ésteres de alquilo (divisional de solicitud n° 1387-2010) |